US Stock MarketDetailed Quotes

SPRO Spero Therapeutics

Watchlist
  • 1.720
  • -0.030-1.71%
Close Mar 28 16:00 ET
  • 1.690
  • -0.030-1.74%
Post 19:52 ET
92.65MMarket Cap4.00P/E (TTM)

Spero Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
99.13%96.74M
54.95%71.83M
2,061.00%23.38M
-12.05%788K
199.60%740K
1,482.38%48.58M
18,007.03%46.35M
52.82%1.08M
-57.45%896K
247K
Operating revenue
99.13%96.74M
54.95%71.83M
2,061.00%23.38M
-12.05%788K
199.60%740K
1,482.38%48.58M
18,007.03%46.35M
52.82%1.08M
-57.45%896K
--247K
Cost of revenue
Gross profit
Operating expense
-11.62%69.95M
3.88%21.29M
53.12%20.01M
-9.58%13.68M
-50.85%14.97M
-13.07%79.15M
-26.16%20.5M
-43.75%13.07M
-26.74%15.13M
56.96%30.45M
Selling and administrative expenses
-29.96%25.55M
-0.95%6.43M
-13.93%5.71M
-24.28%6.1M
-52.19%7.32M
-12.51%36.48M
-50.12%6.5M
-40.53%6.63M
-12.76%8.05M
84.42%15.31M
-General and administrative expense
-29.96%25.55M
-0.95%6.43M
-13.93%5.71M
-24.28%6.1M
-52.19%7.32M
-12.51%36.48M
-50.12%6.5M
-40.53%6.63M
-12.76%8.05M
84.42%15.31M
Research and development costs
8.08%51.44M
9.73%16.56M
122.73%16.39M
16.36%9.51M
-47.09%8.98M
-26.24%47.59M
-12.40%15.09M
-49.02%7.36M
-43.48%8.17M
-7.79%16.97M
Other operating expenses
-42.92%-7.05M
-56.12%-1.7M
-126.30%-2.09M
-75.75%-1.93M
27.06%-1.33M
67.54%-4.93M
56.31%-1.09M
60.78%-924K
63.94%-1.1M
75.04%-1.82M
Operating profit
187.63%26.79M
95.43%50.53M
128.13%3.37M
9.42%-12.89M
52.90%-14.23M
65.25%-30.57M
194.02%25.86M
46.79%-11.99M
23.25%-14.23M
-55.68%-30.21M
Net non-operating interest income expense
362.64%3.94M
45.87%1.04M
356.73%950K
16,466.67%982K
139.86%963K
5.96%-1.5M
138.36%715K
131.11%208K
-107.32%-6K
-2,565.31%-2.42M
Non-operating interest income
255.97%3.94M
45.87%1.04M
356.73%950K
784.68%982K
1,237.50%963K
219.65%1.11M
840.79%715K
131.11%208K
35.37%111K
-26.53%72K
Non-operating interest expense
--0
--0
--0
--0
--0
34.28%2.61M
--0
--0
--117K
--2.49M
Other net income (expense)
62.92%-5.32M
-98.49%3K
-5,261.17%-5.32M
99.96%-6K
99.03%-2K
-7,412.57%-14.35M
57.94%199K
218.39%103K
-12,797.32%-14.45M
-74.58%-206K
Gain on sale of security
----
----
----
----
----
349.51%917K
--141K
---26K
--995K
---193K
Special income (charges)
54.38%-5.31M
--0
-3,590.79%-5.31M
--0
----
---11.63M
--3.65M
--152K
---15.43M
----
-Less:Restructuring and merger&acquisition
--0
--0
--0
--0
----
--11.63M
---67K
---152K
--11.85M
----
-Less:Impairment of capital assets
--5.31M
--0
--5.31M
----
----
--0
--0
--0
----
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--3.58M
----
Other non- operating income (expenses)
99.61%-14K
100.08%3K
56.52%-10K
40.00%-6K
84.62%-2K
-820.51%-3.64M
-4,502.56%-3.59M
73.56%-23K
91.07%-10K
88.98%-13K
Income before tax
154.73%25.4M
92.66%51.58M
91.49%-994K
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
-54.44%-28.68M
-69.02%-32.83M
Income tax
2.6M
387K
2.21M
0
0
0
Net income
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
-54.44%-28.68M
-69.02%-32.83M
Net income continuous Operations
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
-54.44%-28.68M
-69.02%-32.83M
Minority interest income
Net income attributable to the parent company
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
-54.44%-28.68M
-69.02%-32.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
149.13%22.81M
91.22%51.19M
72.55%-3.21M
58.46%-11.91M
59.59%-13.27M
48.29%-46.42M
191.56%26.77M
48.16%-11.68M
-54.44%-28.68M
-69.02%-32.83M
Basic earnings per share
134.96%0.43
76.36%0.97
81.82%-0.06
73.56%-0.23
75.25%-0.25
57.73%-1.23
159.78%0.55
52.86%-0.33
-38.10%-0.87
-53.03%-1.01
Diluted earnings per share
134.96%0.43
76.36%0.97
81.82%-0.06
73.56%-0.23
75.25%-0.25
57.73%-1.23
159.78%0.55
52.86%-0.33
-38.10%-0.87
-53.03%-1.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 99.13%96.74M54.95%71.83M2,061.00%23.38M-12.05%788K199.60%740K1,482.38%48.58M18,007.03%46.35M52.82%1.08M-57.45%896K247K
Operating revenue 99.13%96.74M54.95%71.83M2,061.00%23.38M-12.05%788K199.60%740K1,482.38%48.58M18,007.03%46.35M52.82%1.08M-57.45%896K--247K
Cost of revenue
Gross profit
Operating expense -11.62%69.95M3.88%21.29M53.12%20.01M-9.58%13.68M-50.85%14.97M-13.07%79.15M-26.16%20.5M-43.75%13.07M-26.74%15.13M56.96%30.45M
Selling and administrative expenses -29.96%25.55M-0.95%6.43M-13.93%5.71M-24.28%6.1M-52.19%7.32M-12.51%36.48M-50.12%6.5M-40.53%6.63M-12.76%8.05M84.42%15.31M
-General and administrative expense -29.96%25.55M-0.95%6.43M-13.93%5.71M-24.28%6.1M-52.19%7.32M-12.51%36.48M-50.12%6.5M-40.53%6.63M-12.76%8.05M84.42%15.31M
Research and development costs 8.08%51.44M9.73%16.56M122.73%16.39M16.36%9.51M-47.09%8.98M-26.24%47.59M-12.40%15.09M-49.02%7.36M-43.48%8.17M-7.79%16.97M
Other operating expenses -42.92%-7.05M-56.12%-1.7M-126.30%-2.09M-75.75%-1.93M27.06%-1.33M67.54%-4.93M56.31%-1.09M60.78%-924K63.94%-1.1M75.04%-1.82M
Operating profit 187.63%26.79M95.43%50.53M128.13%3.37M9.42%-12.89M52.90%-14.23M65.25%-30.57M194.02%25.86M46.79%-11.99M23.25%-14.23M-55.68%-30.21M
Net non-operating interest income expense 362.64%3.94M45.87%1.04M356.73%950K16,466.67%982K139.86%963K5.96%-1.5M138.36%715K131.11%208K-107.32%-6K-2,565.31%-2.42M
Non-operating interest income 255.97%3.94M45.87%1.04M356.73%950K784.68%982K1,237.50%963K219.65%1.11M840.79%715K131.11%208K35.37%111K-26.53%72K
Non-operating interest expense --0--0--0--0--034.28%2.61M--0--0--117K--2.49M
Other net income (expense) 62.92%-5.32M-98.49%3K-5,261.17%-5.32M99.96%-6K99.03%-2K-7,412.57%-14.35M57.94%199K218.39%103K-12,797.32%-14.45M-74.58%-206K
Gain on sale of security --------------------349.51%917K--141K---26K--995K---193K
Special income (charges) 54.38%-5.31M--0-3,590.79%-5.31M--0-------11.63M--3.65M--152K---15.43M----
-Less:Restructuring and merger&acquisition --0--0--0--0------11.63M---67K---152K--11.85M----
-Less:Impairment of capital assets --5.31M--0--5.31M----------0--0--0--------
-Less:Other special charges ----------------------------------3.58M----
Other non- operating income (expenses) 99.61%-14K100.08%3K56.52%-10K40.00%-6K84.62%-2K-820.51%-3.64M-4,502.56%-3.59M73.56%-23K91.07%-10K88.98%-13K
Income before tax 154.73%25.4M92.66%51.58M91.49%-994K58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M-54.44%-28.68M-69.02%-32.83M
Income tax 2.6M387K2.21M000
Net income 149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M-54.44%-28.68M-69.02%-32.83M
Net income continuous Operations 149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M-54.44%-28.68M-69.02%-32.83M
Minority interest income
Net income attributable to the parent company 149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M-54.44%-28.68M-69.02%-32.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 149.13%22.81M91.22%51.19M72.55%-3.21M58.46%-11.91M59.59%-13.27M48.29%-46.42M191.56%26.77M48.16%-11.68M-54.44%-28.68M-69.02%-32.83M
Basic earnings per share 134.96%0.4376.36%0.9781.82%-0.0673.56%-0.2375.25%-0.2557.73%-1.23159.78%0.5552.86%-0.33-38.10%-0.87-53.03%-1.01
Diluted earnings per share 134.96%0.4376.36%0.9781.82%-0.0673.56%-0.2375.25%-0.2557.73%-1.23159.78%0.5552.86%-0.33-38.10%-0.87-53.03%-1.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg